Pharmaceutical discount agreement for Omalizumab via Open-House model
Conclusion of a non-exclusive pharmaceutical discount agreement for the active substance Omalizumab (ATC code R03DX05) according to § 130a para. 8 SGB V via an Open-House model.
CONTRACTING AUTHORITY
Name
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
City
Erfurt
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
not-allowed
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
449 days remaining(LOT-0001)
Published